PT  - JOURNAL ARTICLE
AU  - Rozeman, Elisa A
AU  - Versluis, Judith M
AU  - Sikorska, Karolina
AU  - Hoefsmit, Esmée P
AU  - Dimitriadis, Petros
AU  - Rao, Disha
AU  - Lacroix, Ruben
AU  - Grijpink-Ongering, Lindsay G
AU  - Lopez-Yurda, Marta
AU  - Heeres, Birthe C
AU  - van de Wiel, Bart A
AU  - Flohil, Claudie
AU  - Sari, Aysegul
AU  - Heijmink, Stijn W T P J
AU  - van den Broek, Daan
AU  - Broeks, Annegien
AU  - de Groot, Jan Willem B
AU  - Vollebergh, Marieke A
AU  - Wilgenhof, Sofie
AU  - van Thienen, Johannes V
AU  - Haanen, John B A G
AU  - Blank, Christian U
TI  - IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation
AID  - 10.1136/jitc-2023-006821
DP  - 2023 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006821
VI  - 11
IP  - 7
4099  - http://jitc.bmj.com/content/11/7/e006821.short
4100  - http://jitc.bmj.com/content/11/7/e006821.full
SO  - J Immunother Cancer2023 Jul 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.